ALLO
Price
$2.68
Change
-$0.00 (-0.00%)
Updated
Oct 28 closing price
2 days until earnings call
LRMR
Price
$8.01
Change
-$0.00 (-0.00%)
Updated
Oct 28 closing price
14 days until earnings call
Ad is loading...

ALLO vs LRMR

Header iconALLO vs LRMR Comparison
Open Charts ALLO vs LRMRBanner chart's image
Allogene Therapeutics
Price$2.68
Change-$0.00 (-0.00%)
Volume$3.09M
CapitalizationN/A
Larimar Therapeutics
Price$8.01
Change-$0.00 (-0.00%)
Volume$436.48K
CapitalizationN/A
View a ticker or compare two or three
ALLO vs LRMR Comparison Chart
Loading...
ALLO
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
LRMR
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
ALLO vs. LRMR commentary
Oct 30, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALLO is a StrongBuy and LRMR is a StrongBuy.

COMPARISON
Comparison
Oct 30, 2024
Stock price -- (ALLO: $2.68 vs. LRMR: $8.02)
Brand notoriety: ALLO and LRMR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALLO: 151% vs. LRMR: 60%
Market capitalization -- ALLO: $608.51M vs. LRMR: $416.66M
ALLO [@Biotechnology] is valued at $608.51M. LRMR’s [@Biotechnology] market capitalization is $416.66M. The market cap for tickers in the [@Biotechnology] industry ranges from $531.34B to $0. The average market capitalization across the [@Biotechnology] industry is $2.92B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALLO’s FA Score shows that 0 FA rating(s) are green whileLRMR’s FA Score has 1 green FA rating(s).

  • ALLO’s FA Score: 0 green, 5 red.
  • LRMR’s FA Score: 1 green, 4 red.
According to our system of comparison, LRMR is a better buy in the long-term than ALLO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALLO’s TA Score shows that 5 TA indicator(s) are bullish while LRMR’s TA Score has 5 bullish TA indicator(s).

  • ALLO’s TA Score: 5 bullish, 3 bearish.
  • LRMR’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, ALLO is a better buy in the short-term than LRMR.

Price Growth

ALLO (@Biotechnology) experienced а -4.29% price change this week, while LRMR (@Biotechnology) price change was +6.44% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.91%. For the same industry, the average monthly price growth was +2.47%, and the average quarterly price growth was -6.27%.

Reported Earning Dates

ALLO is expected to report earnings on Feb 26, 2025.

LRMR is expected to report earnings on Mar 12, 2025.

Industries' Descriptions

@Biotechnology (+0.91% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ALLO($609M) has a higher market cap than LRMR($417M). LRMR YTD gains are higher at: 76.154 vs. ALLO (-16.511). LRMR has higher annual earnings (EBITDA): -65.51M vs. ALLO (-256.56M). ALLO has more cash in the bank: 445M vs. LRMR (226M). LRMR has less debt than ALLO: LRMR (5.6M) vs ALLO (87M). ALLO has higher revenues than LRMR: ALLO (65K) vs LRMR (0).
ALLOLRMRALLO / LRMR
Capitalization609M417M146%
EBITDA-256.56M-65.51M392%
Gain YTD-16.51176.154-22%
P/E RatioN/AN/A-
Revenue65K0-
Total Cash445M226M197%
Total Debt87M5.6M1,555%
FUNDAMENTALS RATINGS
ALLO vs LRMR: Fundamental Ratings
ALLO
LRMR
OUTLOOK RATING
1..100
6120
VALUATION
overvalued / fair valued / undervalued
1..100
97
Overvalued
30
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
96100
PRICE GROWTH RATING
1..100
7937
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

LRMR's Valuation (30) in the null industry is significantly better than the same rating for ALLO (97) in the Biotechnology industry. This means that LRMR’s stock grew significantly faster than ALLO’s over the last 12 months.

LRMR's Profit vs Risk Rating (100) in the null industry is in the same range as ALLO (100) in the Biotechnology industry. This means that LRMR’s stock grew similarly to ALLO’s over the last 12 months.

ALLO's SMR Rating (96) in the Biotechnology industry is in the same range as LRMR (100) in the null industry. This means that ALLO’s stock grew similarly to LRMR’s over the last 12 months.

LRMR's Price Growth Rating (37) in the null industry is somewhat better than the same rating for ALLO (79) in the Biotechnology industry. This means that LRMR’s stock grew somewhat faster than ALLO’s over the last 12 months.

LRMR's P/E Growth Rating (100) in the null industry is in the same range as ALLO (100) in the Biotechnology industry. This means that LRMR’s stock grew similarly to ALLO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ALLOLRMR
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
86%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
83%
MACD
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
86%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
86%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 14 days ago
80%
Bullish Trend 2 days ago
87%
Declines
ODDS (%)
Bearish Trend 5 days ago
86%
Bearish Trend 20 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 6 days ago
75%
Bearish Trend 2 days ago
88%
View a ticker or compare two or three
Ad is loading...
ALLO
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
LRMR
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME22.732.16
+10.50%
GameStop Corp
BTC.X69907.7600001978.460900
+2.91%
Bitcoin cryptocurrency
AAPL233.401.99
+0.86%
Apple
SPY580.831.79
+0.31%
SPDR® S&P 500® ETF Trust
TSLA262.51-6.68
-2.48%
Tesla

LRMR and

Correlation & Price change

A.I.dvisor indicates that over the last year, LRMR has been loosely correlated with SVRA. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if LRMR jumps, then SVRA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LRMR
1D Price
Change %
LRMR100%
+0.06%
SVRA - LRMR
41%
Loosely correlated
+1.15%
ROIV - LRMR
40%
Loosely correlated
-0.67%
PLRX - LRMR
39%
Loosely correlated
+5.02%
ERAS - LRMR
39%
Loosely correlated
+0.36%
ABUS - LRMR
38%
Loosely correlated
+2.02%
More